Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Infectious Diseases Now
|
February 28, 2025
Safe early switch to oral antibiotics in immunocompetent adults with intracranial bacterial suppurations: Retrospective of a 25-year experience in a tertiary care centre
Aurélie Besnard, Anne-Marie Korinek, Rémy Bernard, et al.
Journal of Clinical Medicine
|
September 16, 2020
Autism and COVID-19: A Case Series in a Neurodevelopmental Unit
Leslie Nollace, Cora Cravero, Alice Abbou, et al.
Plos One
|
October 3, 2012
The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities
Sophie Vimont, Anders Boyd, Alexandre Bleibtreu, et al.
Microbiologyopen
|
June 3, 2015
Quantitative analysis of commensal Escherichia coli populations reveals host-specific enterotypes at the intra-species level
Mounira Smati, Olivier Clermont, Alexandre Bleibtreu, et al.
The Journal of Antimicrobial Chemotherapy
|
March 19, 2025
Prophylaxis against Pneumocystis jirovecii pneumonia and toxoplasmosis with low-dose Trimethoprim-sulfamethoxazole (cotrimoxazole 20/100 mg) in heart transplant patients. The PAPTO-LOCO observational comparative study
Dahlia Aggoun, Constance Verdonk, Alexandre Bleibtreu, et al.
Porto Biomedical Journal
|
May 22, 2023
Dual beta-lactam treatment: Pros and cons
Diogo Guerra, Pauline Vidal, Olivier Paccoud, et al.
BMC Medical Education
|
November 1, 2020
How and why do French medical students choose the specialty of infectious and tropical diseases? A national cross-sectional study
Nathan Peiffer-Smadja, François-Daniel Ardellier, Pauline Thill, et al.
Journal of Clinical Medicine
|
November 20, 2020
Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
Yaniss Belaroussi, Paul Roblot, Nathan Peiffer-Smadja, et al.
Infectious Diseases Now
|
February 10, 2025
Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIE
Lionel Piroth, Virginie Vitrat, Vincent Le Moing, et al.
Nephrologie & Therapeutique
|
November 2, 2023
COVID-19 early curative treatments in kidney transplant recipients: is it really reasonable at the Omicron era?
Yanis Tamzali, Alexia Lundy, Alexandre Bleibtreu, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Infectious Diseases Now
|
February 28, 2025
Safe early switch to oral antibiotics in immunocompetent adults with intracranial bacterial suppurations: Retrospective of a 25-year experience in a tertiary care centre
Aurélie Besnard, Anne-Marie Korinek, Rémy Bernard, et al.
Journal of Clinical Medicine
|
September 16, 2020
Autism and COVID-19: A Case Series in a Neurodevelopmental Unit
Leslie Nollace, Cora Cravero, Alice Abbou, et al.
Plos One
|
October 3, 2012
The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities
Sophie Vimont, Anders Boyd, Alexandre Bleibtreu, et al.
Microbiologyopen
|
June 3, 2015
Quantitative analysis of commensal Escherichia coli populations reveals host-specific enterotypes at the intra-species level
Mounira Smati, Olivier Clermont, Alexandre Bleibtreu, et al.
The Journal of Antimicrobial Chemotherapy
|
March 19, 2025
Prophylaxis against Pneumocystis jirovecii pneumonia and toxoplasmosis with low-dose Trimethoprim-sulfamethoxazole (cotrimoxazole 20/100 mg) in heart transplant patients. The PAPTO-LOCO observational comparative study
Dahlia Aggoun, Constance Verdonk, Alexandre Bleibtreu, et al.
Porto Biomedical Journal
|
May 22, 2023
Dual beta-lactam treatment: Pros and cons
Diogo Guerra, Pauline Vidal, Olivier Paccoud, et al.
BMC Medical Education
|
November 1, 2020
How and why do French medical students choose the specialty of infectious and tropical diseases? A national cross-sectional study
Nathan Peiffer-Smadja, François-Daniel Ardellier, Pauline Thill, et al.
Journal of Clinical Medicine
|
November 20, 2020
Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
Yaniss Belaroussi, Paul Roblot, Nathan Peiffer-Smadja, et al.
Infectious Diseases Now
|
February 10, 2025
Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIE
Lionel Piroth, Virginie Vitrat, Vincent Le Moing, et al.
Nephrologie & Therapeutique
|
November 2, 2023
COVID-19 early curative treatments in kidney transplant recipients: is it really reasonable at the Omicron era?
Yanis Tamzali, Alexia Lundy, Alexandre Bleibtreu, et al.
Page
of 7